Crossmark

Head-to-head: meropenem/vaborbactam versus ceftazidime/avibactam in ICUs patients with KPC-producing K. pneumoniae infections– results from a retrospective multicentre study

Crossref DOI link: https://doi.org/10.1007/s15010-025-02608-7

Published Online: 2025-07-16

Published Print: 2025-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Marino, Andrea

Maraolo, Alberto Enrico

Mazzitelli, Maria

Oliva, Alessandra

Geremia, Nicholas

De Vito, Andrea

Gullotta, Chiara

Scaglione, Vincenzo

Vania, Eleonora

Lo Menzo, Sara

Navalesi, Paolo

Volpicelli, Lorenzo

Fiori, Andrea

Prestifilippo, Pamela

Cattelan, Annamaria

Mastroianni, Claudio Maria

Madeddu, Giordano

Cacopardo, Bruno

Nunnari, Giuseppe
License Information

Text and Data Mining valid from 2025-07-16

Version of Record valid from 2025-07-16
More Information

Article History

Received: 15 March 2025

Accepted: 8 July 2025

First Online: 16 July 2025

Declarations

:

: The study was approved by the local Ethical Committees (no. 101/CECT2; no. 0069/2022 and 0341/2023). The study was conducted according to the guidelines of the Declaration of Helsinki.

: Informed consent was waived due to the retrospective nature of the research.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below